KLTO — Klotho Neurosciences Balance Sheet
0.000.00%
- $42.24m
- $33.81m
- 39
- 17
- 36
- 19
Annual balance sheet for Klotho Neurosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | 0.005 | 0.341 | 0.173 | 0.064 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 0.005 | 0.44 | 0.2 | 0.158 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Total Assets | 0.005 | 118 | 19.5 | 2.46 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.009 | 0.506 | 2.31 | 1.25 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 0.009 | 4.93 | 8.24 | 1.27 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | -0.004 | 113 | 11.2 | 1.19 |
| Total Liabilities & Shareholders' Equity | 0.005 | 118 | 19.5 | 2.46 |
| Total Common Shares Outstanding |